PLAU and breast cancer: Both PAI-1 and uPA belong to progression and metastasis markers of BC to predict the benefit effectiveness of adjuvant chemotherapy in patients with early BC, and are used as prognostic biomarkers in lymph node-negative BC [23,24,54].